Filing Details

Accession Number:
0001493152-21-030431
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-03 16:15:37
Reporting Period:
2021-12-01
Accepted Time:
2021-12-03 16:15:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1641631 Beyond Air Inc. XAIR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1426873 Amir Avniel C/O Beyond Air, Inc.
900 Stewart Avenue, Suite 301
Garden City NY 11530
Coo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-12-01 32,675 $13.72 403,527 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. As previously reported, on November 23, 2021, shares of common stock, par value $0.0001 per share, of Beyond Air, Inc. (the "Company") were issued to the reporting person in connection with the exercise of a warrant to purchase 43,334 shares of common stock of the Company for $3.66 a share on a cashless exercise basis, resulting in the Company's withholding of 10,659 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 32,675 shares of common stock of the Company. These transactions were exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3. On December 1, 2021, the reporting person sold the 32,675 shares of common stock of the Company acquired in connection with the warrant exercise.
  2. The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.46 to $14.25, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.